Clinical SaaS analytics platform revolutionizing medical imaging and healthcare through ultra-fast cloud computing, advanced visualization, and deep learning.

Arterys

Science

United States of America

With the evolving industrialization of life sciences, companies need to embrace the exponential changes in technology to change the way they work, conduct research, innovate, manufacture and distribute products, and meet consumer expectations. The life sciences sector continues to embark on a transformative technology journey. Companies, today, are preparing for the future by embracing these technologies and building a patient-centric culture. Life sciences companies operate in an evolving business environment that is characterized by cost pressure, technological progress and disruption caused by new, innovative market participants. In this context, the market focus is shifting from product sales to health outcomes. Biopharma and biotech companies are increasingly looking to data science, artificial intelligence (AI) and machine learning to give new insights into drug development. While uptake in artificial intelligence may seem slow in life sciences compared to other industries, the potential shift it represents will indelibly impact the way drugs and medical devices are discovered, designed, created, distributed, and used. AI will drive more combination products, higher quality, and more personalization across the industry.

Careers and Openings at Arterys